Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can structured nursing care help people with dementia cope better, in person or in virtual reality?

NCT ID NCT07816731

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 14, 2026 · Last updated Sep 15, 2026 · Updated 1 time

Summary

Researchers are testing nursing care built on the Salutogenesis Model, which aims to strengthen a person's sense of coherence: how understandable, manageable, and meaningful life feels. The study enrolls 73 adults with mild to moderate dementia and assigns them to face-to-face sessions, virtual reality sessions, or usual care. Participants in the active groups receive weekly sessions for eight weeks, and researchers measure sense of coherence and quality of life at the start, after the program, and about three months later to see whether any changes last.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
nursing care based on the Salutogenesis Model, delivered face-to-face or through virtual reality
What this could lead to
If it helps, this approach could give dementia care teams a structured way to support coping and daily well-being, with virtual reality as an option when in-person sessions are hard to arrange.
What could go wrong
This is a small study of 73 people with mild to moderate dementia, and it measures sense of coherence and quality of life rather than disease outcomes. The benefits may be modest, may not last after sessions end, and may not apply to people with severe dementia or other conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 73 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * -Individuals aged 18 years and older. * Individuals who are able to read and write. * Individuals with a Standardized Mini-Mental Test (SMMT) score between 11 and 23, indicating mild to moderate dementia. * Individuals without severe speech or language impairments that would limit communication. * Individuals with non-progressive or clinically stable dementia, defined as cognitive symptoms that do not show marked deterioration over time. * Individuals who have provided written informed consent, or whose legal representative has provided written informed consent. * Individuals who are able to participate in the intervention sessions using virtual reality headsets independently or with the support of a caregiver. Exclusion Criteria: * Inability to complete assessments due to severe psychotic symptoms (e.g., hallucinations, paranoid thoughts) or uncontrolled behavioral symptoms such as aggression or severe agitation. * Presence of progressive neurological diseases that impair motor and cognitive functions, such as Parkinson's disease or Huntington's disease. * A Standardized Mini-Mental Test (SMMT) score below 10. * Being older than 80 years of age. * Absence of a caregiver.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dementia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Niğde/Bor

    RECRUITING

    Niğde, Bor, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.